Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$536M |
| 2 |
Apple
AAPL
|
+$362M |
| 3 |
Micron Technology
MU
|
+$270M |
| 4 |
Eli Lilly
LLY
|
+$228M |
| 5 |
Cisco
CSCO
|
+$179M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
Tesla
TSLA
|
+$463M |
| 3 |
NVIDIA
NVDA
|
+$424M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Meta Platforms (Facebook)
META
|
+$228M |
Sector Composition
| 1 | Technology | 19.7% |
| 2 | Healthcare | 16.66% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Industrials | 9.61% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
NexGel
NXGL
$20.4M
| $73.4K | ﹤0.01% |
28,455
+2,624
| +10% | +$6.77K |
|
3302
Biodesix
BDSX
$60.5M
| $73.3K | ﹤0.01% |
41,157
+30,057
| +271% | +$53.5K |
|
3303
Eve Holding
EVEX
$1.17B
| $73.2K | ﹤0.01% |
+22,600
| New | +$73.2K |
|
3304
Rapid Micro Biosystems
RPID
$135M
| $73.1K | ﹤0.01% |
82,145
+16,158
| +24% | +$14.4K |
|
3305
CS Disco
LAW
$356M
| $72.9K | ﹤0.01% |
12,400
-133,200
| -91% | -$783K |
|
3306
Coda Octopus Group
CODA
$86.3M
| $72.6K | ﹤0.01% |
+10,014
| New | +$72.6K |
|
3307
Rani Therapeutics
RANI
$23.9M
| $71.7K | ﹤0.01% |
33,199
+11,499
| +53% | +$24.8K |
|
3308
urban-gro
UGRO
$8.37M
| $71.6K | ﹤0.01% |
51,900
+1,900
| +4% | +$2.62K |
|
|
AXDX
3309
DELISTED
Accelerate Diagnostics
AXDX
| $70.2K | ﹤0.01% |
+41,078
| New | +$70.2K |
|
|
FENG
3310
Phoenix New Media
FENG
$31.5M
| $70K | ﹤0.01% |
21,931
-1,900
| -8% | -$6.06K |
|
3311
Celularity
CELU
$62.2M
| $69.4K | ﹤0.01% |
23,380
-2,118
| -8% | -$6.29K |
|
3312
Nexalin Technology
NXL
$14.6M
| $68.8K | ﹤0.01% |
+102,900
| New | +$68.8K |
|
3313
Sana Biotechnology
SANA
$831M
| $68.6K | ﹤0.01% |
16,500
-33,400
| -67% | -$139K |
|
3314
Xenetic Biosciences
XBIO
$4.92M
| $68.5K | ﹤0.01% |
+15,850
| New | +$68.5K |
|
3315
Aterian
ATER
$9.75M
| $67.8K | ﹤0.01% |
+23,535
| New | +$67.8K |
|
3316
Imunon
IMNN
$14.4M
| $67.4K | ﹤0.01% |
4,877
-3,657
| -43% | -$50.6K |
|
3317
Lightbridge
LTBR
$363M
| $67.2K | ﹤0.01% |
24,000
+800
| +3% | +$2.24K |
|
|
ATON
3318
AlphaTON Capital Corp. Common Stock
ATON
$34.8M
| $66.9K | ﹤0.01% |
10,058
+6,268
| +165% | +$41.7K |
|
3319
Milestone Scientific
MLSS
$46.5M
| $66.5K | ﹤0.01% |
73,077
+29,180
| +66% | +$26.6K |
|
3320
Mesa Air Group
MESA
$58.2M
| $66.3K | ﹤0.01% |
54,800
+21,500
| +65% | +$26K |
|
|
AIM
3321
AIM ImmunoTech Inc.
AIM
$6.99M
| $65.7K | ﹤0.01% |
2,432
+144
| +6% | +$3.89K |
|
|
WPRT
3322
Westport Fuel Systems
WPRT
$40.8M
| $65.1K | ﹤0.01% |
14,182
+2,200
| +18% | +$10.1K |
|
3323
Davis Commodities Limited Class A Ordinary Shares
DTCK
$22.1M
| $64K | ﹤0.01% |
+60,994
| New | +$64K |
|
3324
SurgePays
SURG
$56.6M
| $63.3K | ﹤0.01% |
34,400
+20,200
| +142% | +$37.2K |
|
|
YQ
3325
17 Education & Technology Group
YQ
$23M
| $61.8K | ﹤0.01% |
20,730
+200
| +1% | +$596 |
|